1. Home
  2. FORM vs PRAX Comparison

FORM vs PRAX Comparison

Compare FORM & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FormFactor Inc. FormFactor Inc.

FORM

FormFactor Inc. FormFactor Inc.

N/A

Current Price

$148.44

Market Cap

9.0B

Sector

Technology

ML Signal

N/A

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

N/A

Current Price

$286.91

Market Cap

8.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FORM
PRAX
Founded
1993
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
8.3B
IPO Year
2002
2020

Fundamental Metrics

Financial Performance
Metric
FORM
PRAX
Price
$148.44
$286.91
Analyst Decision
Buy
Strong Buy
Analyst Count
10
19
Target Price
$138.63
★ $638.68
AVG Volume (30 Days)
★ 965.4K
357.8K
Earning Date
10-28-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.96
N/A
Revenue
N/A
N/A
Revenue This Year
$30.88
N/A
Revenue Next Year
$17.12
$39,590.54
P/E Ratio
$146.28
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$37.14
$50.31
52 Week High
$160.27
$392.70

Technical Indicators

Market Signals
Indicator
FORM
PRAX
Relative Strength Index (RSI) 70.82 35.63
Support Level $113.14 $282.35
Resistance Level $158.56 $354.17
Average True Range (ATR) 5.71 14.63
MACD 3.76 -1.65
Stochastic Oscillator 94.09 21.96

Price Performance

Historical Comparison
FORM
PRAX

About FORM FormFactor Inc. FormFactor Inc.

FormFactor Inc is a provider of electrical and optical test and measurement technologies along the full semiconductor product lifecycle - from characterization, modeling, reliability, and design de-bug, to qualification and production test.. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: